Combination Of Anti-Cd19 And Anti-Cd20 Chimeric Antigen Receptor T Cells For Relapsed And Refractory Diffuse Larger B Cell Lymphoma: An Open-Label, Single-Arm, Phase I/Ii Trial
BLOOD（2019）
摘要
Objective
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要